Browsing by Subject "Disorders"

Now showing items 1-4 of 4

    • Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids 
      Robles Díaz, M.; González Jiménez, A.; Medina Cáliz, I.; Stephens, C.; García Cortés, M.; García Muñoz, B.; Ortega Alonso, A.; Blanco Reina, E.; González Grande, R.; Jiménez Pérez, M.; Rendon, P.; Navarro, J. M.; Gines, P.; Prieto, M.; García Eliz, M.; Bessone, F.; Brahm Barril, Javier; Paraná, R.; Lucena, M. I.; Andrade, R. J. (John Wiley, 2015)
      Background We have observed an increase in hepatotoxicity (DILI) reporting related to the use of anabolic androgenic steroids (AAS) for bodybuilding. Aim To characterise phenotype presentation, outcome and severity of ...
    • Does a systematic vocal exercise program enhance the physiologic range of voice production in classical ... 
      Guzmán, Marco; Angadi, Vrushali; Croake, Daniel; Catalán, Christopher; Romero Riveros, Constanza; Acuña, Gabriela; Quezada Gaponov, Camilo; Andreatta, Richard; Stemple, Joseph (American Speech-Language-Hearing Association (ASHA), 2020)
      Purpose: The purpose of this study was to assess the effects of vocal function exercises (VFEs) on the physiologic range of the operatic voice. The primary outcome measure was total voice range profile (VRP) area. Method: ...
    • Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease 
      Cuchacovich Turteltaub, Miguel; Solanes, Federica; Pérez, Claudio; Verdaguer, Juan Ignacio; Verdaguer, Juan; Castiglione, Enzo; Carpentier, Cristian; Traipe, Leonidas; Villarroel, Francisco (Mary Ann Liebert, 2016)
      Purpose: To study the efficacy and incidence of treatment-related side effects of mycophenolate mofetil (MMF) therapy in patients with noninfectious inflammatory eye diseases. Methods: Retrospective cohort study of 27 ...
    • Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive ... 
      Guevara Oliva, Carlos; Bulatova, K.; Barker, G. J.; González, G.; Crossley, N.; Kempton, M. J. (Hindawi, 2016)
      In multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), the absence of surrogate endpoints makes clinical trials long and expensive. We aim to determine annualized whole-brain atrophy rates (a-WBAR) in ...